Can Polycythemia Cause Bone Lesions?
Polycythemia vera (PV) does not typically cause osteolytic bone lesions as a direct disease manifestation, but bone abnormalities can occur through several mechanisms: osteoporosis from the disease itself, bone marrow expansion in advanced myelofibrosis, and rarely, osteolytic lesions from leukemic transformation.
Bone Manifestations in Polycythemia Vera
Osteoporosis - The Primary Bone Complication
The most common bone abnormality in PV is osteoporosis, not osteolytic lesions. Research demonstrates that PV is associated with decreased bone mass and reduced osteoblast activity 1. A mouse model of PV showed trabecular bone loss with decreased osteoblast numbers and bone formation, while osteoclast activity remained normal 1.
Clinical evidence supports this finding - a case report documented severe osteoporosis developing in a 51-year-old woman within 8 years of PV diagnosis 2. Historical bone studies from 1969 found that some PV patients had osteoporotic bone, with no new bone formation detected 3.
Bone Marrow Expansion in Advanced Disease
In advanced PV with progression to myelofibrosis, bone changes occur from marrow space expansion rather than true osteolytic lesions. A bone scan case showed diffuse prominence of long bones, especially in metaphyseal and epiphyseal regions, reflecting marrow expansion from myelofibrosis 4. The 1969 study confirmed that new bone formation in myelosclerosis resulted from ossification of argyrophilic fibers in marrow, not from osteolytic destruction 3.
Osteolytic Lesions - A Red Flag for Transformation
True osteolytic lesions in a PV patient should raise immediate concern for leukemic transformation, not PV itself. A case report described a PV patient presenting with hypercalcemia, anemia, and lytic lesions of the thoracic spine and skull - initially suspected to be multiple myeloma 5. However, bone marrow biopsy revealed extensive bone marrow necrosis, and the patient had transformed to acute myeloid leukemia (AML) 5. This represents malignant transformation (occurring in approximately 6.8% of PV patients 6), not a direct effect of PV.
Clinical Approach
When evaluating bone abnormalities in PV patients:
- Osteoporosis screening should be considered, particularly in patients with long-standing disease or additional risk factors
- Lytic bone lesions warrant immediate investigation for:
- Leukemic transformation (check CBC with differential, peripheral smear, bone marrow biopsy)
- Secondary malignancy
- Multiple myeloma (serum/urine protein electrophoresis, free light chains)
- Diffuse bone prominence on imaging in advanced disease likely represents myelofibrosis-related marrow expansion rather than true lesions
The European LeukemiaNet guidelines 7 and Mayo Clinic recommendations 8 do not list bone lesions as a diagnostic or management consideration in uncomplicated PV, reinforcing that this is not a typical disease manifestation.